Premium
Microneedle‐Based Generation of Microbubbles in Cancer Tumors to Improve Ultrasound‐Assisted Drug Delivery
Author(s) -
Zandi Ashkan,
Khayamian Mohammad Ali,
Saghafi Mohammad,
Shalileh Shahriar,
Katebi Pouyan,
Assadi Sepanta,
Gilani Ali,
Salemizadeh Parizi Mohammad,
Vanaei Shohreh,
Esmailinejad Mohammad Reza,
Abbasvandi Fereshteh,
Hoseinpour Parisa,
Abdolahad Mohammad
Publication year - 2019
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201900613
Subject(s) - microbubbles , sonoporation , paclitaxel , materials science , drug delivery , biomedical engineering , doxorubicin , nanowire , ultrasound , cancer cell , nanoparticle , nanotechnology , cancer research , cancer , medicine , chemotherapy , surgery , radiology
Production of local microbubbles (MBs) with dense distribution in tumor environment is achieved by developing an integrated electrochemical stimulator on a microfabricated silicon needle covered by zinc‐oxide nanowires (ZnONWs). MBs are then exploded by external ultrasonic actuation, which induce microcavitations in tumor cells followed by direct entrance of anticancer drugs into cancer cells. This system, named ZnO nanowire‐based microbubble generator probe (ZnONW‐MGP), is tested on tumorized mice models (by MC4L2 breast cell lines). Mice treated by ZnONW‐MGP have ≈82% reduction in tumor size within 10 days with just 25% of conventional dose of paclitaxel while in the absence of the system, they have just a 15% reduction in tumor size. Presence of ZnO nanostructures on microneedles strongly reduces the size of MBs and enhances the efficacy of the sonoporation.